Resultado da Busca
25 de out. de 2022 · Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian Clinical Registry for Advanced Colorectal Cancer.
15 de jul. de 2016 · Of all patients with metastatic cancer, the most common sites of metastasis were the liver (70% in colon cancer/70% in rectal cancer) and the thorax (32%/47%). In colon cancer, the third most common site was the peritoneum (21%) whereas in rectal cancer it was the bone (12%).
- Matias Riihimäki, Matias Riihimäki, Akseli Hemminki, Jan Sundquist, Kari Hemminki, Kari Hemminki
- 10.1038/srep29765
- 2016
- Sci Rep. 2016; 6: 29765.
17 de out. de 2022 · PDF. Abstract. Purpose. To develop recommendations for treatment of patients with metastatic colorectal cancer (mCRC). Methods. ASCO convened an Expert Panel to conduct a systematic review of relevant studies and develop recommendations for clinical practice. Results.
19 de set. de 2019 · The most common sites of metastasis are the liver and the peritoneum. Peritoneal carcinomatosis is often considered the end stage of the disease after the tumor has spread to the liver. However, almost half of CRC patients with peritoneal carcinomatosis do not present with liver metastasis.
- E. Pretzsch, F. Bösch, J. Neumann, P. Ganschow, A. Bazhin, M. Guba, J. Werner, M. Angele
- 10.1155/2019/7407190
- 2019
- J Oncol. 2019; 2019: 7407190.
Of new colorectal cancer diagnoses, 20% of patients have metastatic disease at presentation and another 25% who present with localized disease will later develop metastases. Observations Colorectal cancer is the third most common cause of cancer mortality for men and women in the United States, with 53 200 deaths projected in 2020.
- Leah H Biller, Deborah Schrag
- 2021
16 de abr. de 2024 · Metastasis is the major cause of death in patients with colorectal cancer 1. The most common metastasis sites of colorectal cancer are the liver, followed by the lung, lymph node, and...
25 de out. de 2022 · Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5 A. Cervantes1,2, R. Adam3, S. Roselló1,2, D. Arnold4, N. Normanno5, J. Taïeb6,7, J. Seligmann8, T. De Baere9,10,11, P. Osterlund12,13, T. Yoshino14 & E. Martinelli15, on behalf of the ESMO Guidelines Committee*
